Literature DB >> 10227457

Involvement of SHP-1, a phosphotyrosine phosphatase, during myeloid cell differentiation in acute promyelocytic leukemia cell lines.

Y Uesugi1, I Fuse, K Toba, K Kishi, T Furukawa, T Koike, Y Aizawa.   

Abstract

We investigated the modulation of the expression and phosphatase activity of SHP-1 during granulocytic differentiation of human myeloid leukemia cell line, HL60 and t(15;17) positive APL cell line, HT93, in response to all-trans retinoic acid (ATRA) or dimethylsulfoxide (DMSO). ATRA induced differentiation in both cell lines which was associated with marked growth inhibition and S-phase reduction. On the other hand, DMSO induced it only in HL60 without obvious growth inhibition and S-phase reduction. The expression and phosphatase activity of SHP-1 were upregulated only when the 2 cell lines were differentiated to granulocytes. Furthermore, the changes were not dependent on the inducers or the growth inhibition. These findings suggest that SHP-1 is involved in common myeloid differentiation, and that upregulation of SHP-1 is not always related to myeloid cell growth.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10227457     DOI: 10.1111/j.1600-0609.1999.tb01753.x

Source DB:  PubMed          Journal:  Eur J Haematol        ISSN: 0902-4441            Impact factor:   2.997


  2 in total

1.  Epigallocatechin-3-gallate induces apoptosis in acute promyelocytic leukemia cells via a SHP-1-p38α MAPK-Bax cascade.

Authors:  Liugen Gan; Liang Zhong; Zhiling Shan; Chunlan Xiao; Ting Xu; Hao Song; Liu Li; Rong Yang; Beizhong Liu
Journal:  Oncol Lett       Date:  2017-09-18       Impact factor: 2.967

2.  Differential cell fates induced by all-trans retinoic acid-treated HL-60 human leukemia cells.

Authors:  Munetaka Ozeki; John E Shively
Journal:  J Leukoc Biol       Date:  2008-06-13       Impact factor: 4.962

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.